secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIGAND PHARMACEUTICALS INC (LGND)
CIK:        0000886163
Form:       8-K
Filed at:   2025-06-09T23:59:59+00:00
Accession:  0000886163-25-000040
Event type: other
Sentiment:  neutral
Materiality: 0.05
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Ligand shareholders re-elect all eight directors, ratify auditor, and approve say-on-pay
--------------------------------------------------------------------------------

- All eight director nominees elected, with each receiving >15.5M votes for (excluding broker non-votes).
- Ratification of Ernst & Young as independent auditor for FY2025 passed with 17.27M votes for.
- Non-binding advisory vote on named executive officer compensation approved with 15.58M votes for.
- Broker non-votes totaled 1.36M on director elections and say-on-pay; none on auditor ratification.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/886163/000088616325000040/0000886163-25-000040-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/886163/000088616325000040/lgnd-20250609.htm
  HTML page:      https://secwatch.observer/filing/0000886163-25-000040

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer